SCHEMBL4126896

SCHEMBL4126896

CC[C@@](O)(NC(=O)C1SCCN1C(=O)OC(C)(C)C)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
RIPK1 Q13546 1/20 0.40
NPC1 O15118 1/20 0.38
STS P08842 1/20 0.37
KDM4E B2RXH2 1/20 0.37
PKM P14618 1/20 0.37
GPR119 Q8TDV5 2/20 0.36
NR1H2 P55055 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
GHSR Q92847 1/20 0.35
PTPN2 P17706 1/20 0.35
PTPN1 P18031 1/20 0.35
PTPN6 P29350 1/20 0.35
LMNA P02545 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALDH1A1 P00352 1/20 0.35
BRD4 O60885 1/20 0.34
RORC P51449 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL201382 0.77 STS (0.43) MEN1KMT2ARIPK1NPC1STS
SCHEMBL201381 0.77 STS (0.43) MEN1KMT2ARIPK1NPC1STS
SCHEMBL3382903 0.75 RIPK1 (0.46) MEN1KMT2ARIPK1STSKDM4E
SCHEMBL3018218 0.74 CA12 (0.43) MEN1KMT2ANPC1NPSR1
SCHEMBL13004626 0.73 PTGFR (0.39) RIPK1STSKDM4EPKM
SCHEMBL3386859 0.73 PTGFR (0.39) RIPK1STSKDM4EPKM
SCHEMBL3385956 0.73 PTGFR (0.39) RIPK1STSKDM4EPKM
SCHEMBL3384021 0.73 ATM (0.39) STSKDM4EPKMGPR119GHSR
SCHEMBL4799833 0.71 ATM (0.37) MEN1KMT2ARIPK1NPC1STS
SCHEMBL200834 0.71 ACE (0.48) RIPK1GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415480-B2 Thiazolidine carboxamide derivatives as modulators of the prostaglandin F receptor MERCK SERONO SA (CH) 2013-04-09 US disclosed
US-20090215749-A9 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR LABORATOIRES SERONO S.A. (CH) 2009-08-27 US disclosed
US-20080255094-A1 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR LABORATOIRES SERONO S.A. (CH) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215749-A9 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR PTGER4, PTGER2, PTGER1 MEN1 4868/4885KMT2A 2053/4885RIPK1 3548/4885
US-20080255094-A1 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR PTGER4, PTGER2, PTGER1 MEN1 4868/4885KMT2A 2053/4885RIPK1 3548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.